Filing Details
- Accession Number:
- 0001055726-23-000004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-28 17:40:24
- Reporting Period:
- 2023-02-26
- Accepted Time:
- 2023-02-28 17:40:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1055726 | Inovio Pharmaceuticals Inc. | INO | Surgical & Medical Instruments & Apparatus (3841) | 330969592 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1669080 | B. David Weiner | 660 W. Germantown Pike Suite 110 Plymouth Meeting PA 19462 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-02-26 | 11,667 | $0.00 | 904,292 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-02-26 | 11,667 | $0.00 | 915,959 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-02-27 | 11,668 | $1.28 | 904,291 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Disposition | 2023-02-26 | 11,667 | $0.00 | 11,667 | $0.00 |
| Common Stock | Restricted Stock Unit | Disposition | 2023-02-26 | 11,667 | $0.00 | 11,667 | $0.00 |
| Common Stock | Common Stock Option | Acquisiton | 2023-02-27 | 60,000 | $0.00 | 60,000 | $1.24 |
| Common Stock | Restricted Stock Unit | Acquisiton | 2023-02-27 | 35,000 | $0.00 | 35,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 11,666 | No | 4 | M | Direct | ||
| 23,333 | No | 4 | M | Direct | ||
| 60,000 | 2023-02-27 | 2033-02-27 | No | 4 | A | Direct |
| 35,000 | No | 4 | A | Direct |
Footnotes
- Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2021, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on February 26, 2022; 11,667 shares vested on February 26, 2023; and 11,666 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
- Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2022, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on February 26, 2023; 11,667 shares will vest on February 26, 2024; and 11,666 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 13, 2022.
- The vesting schedule for the 60,000 options is as follows: 15,000 shares vested on February 27, 2023; 15,000 shares will vest on February 26, 2024; 15,000 shares will vest on February 26, 2025; and 15,000 shares will vest on February 26, 2026.
- Each restricted stock unit represents a contingent right to receive one share of common stock. On February 27, 2023, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares will vest on February 26, 2024; 11,667 shares will vest on February 26, 2025; and 11,666 shares will vest on February 26, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
Billionaire Hedge Funds
